{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:12:21Z","timestamp":1773706341132,"version":"3.50.1"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ejphar.2021.173934","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T17:06:11Z","timestamp":1613581571000},"page":"173934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Metformin turns 62 in pharmacotherapy: Emergence of non-glycaemic effects and potential novel therapeutic applications"],"prefix":"10.1016","volume":"898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8687-001X","authenticated-orcid":false,"given":"Kingsley C.","family":"Mbara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale E.","family":"Mofo Mato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Driver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanelisiwe","family":"Nzuza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ntokozo T.","family":"Mkhombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senamile KP.","family":"Gcwensa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5875-0494","authenticated-orcid":false,"given":"Esethu N.","family":"Mcobothi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter MO.","family":"Owira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.173934_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40425-018-0375-1","article-title":"Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1\/anti-CTLA-4) in metastatic malignant melanoma","volume":"6","author":"Afjal","year":"2018","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ejphar.2021.173934_bib4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/1940-6207.CAPR-11-0536","article-title":"Metformin reduces endogenous reactive oxygen species and associated DNA damage","volume":"5","author":"Algire","year":"2012","journal-title":"Canc. Prev. Res."},{"issue":"12","key":"10.1016\/j.ejphar.2021.173934_bib3","first-page":"FC21","article-title":"Erectile dysfunction and low sex drive in men with type 2 DM: the potential role of diabetic pharmacotherapy","volume":"10","author":"Al-Kuraishy","year":"2016","journal-title":"J. Clin. Diagn. Res."},{"issue":"8","key":"10.1016\/j.ejphar.2021.173934_bib5","doi-asserted-by":"crossref","first-page":"999","DOI":"10.4158\/EP151145.RA","article-title":"Metformin: nonglycemic effects and potential novel indications","volume":"22","author":"Anabtawi","year":"2016","journal-title":"Endocr. Pract."},{"issue":"1","key":"10.1016\/j.ejphar.2021.173934_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1124\/jpet.109.164970","article-title":"Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro","volume":"334","author":"Arai","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"4","key":"10.1016\/j.ejphar.2021.173934_bib7","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1210\/jc.2015-3754","article-title":"Long-term metformin use and vitamin B12 deficiency in the diabetes prevention program outcomes study","volume":"101","author":"Aroda","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2021.173934_bib8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/bcpt.12898","article-title":"Patient- and cell type-specific heterogeneity of metformin response","volume":"122","author":"Asiedu","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2021.173934_bib9","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00125-017-4318-z","article-title":"Metformin: historical overview","volume":"60","author":"Bailey","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2021.173934_bib10","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s00125-008-1053-5","article-title":"Metformin and the intestine","volume":"51","author":"Bailey","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2021.173934_bib11","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1038\/s41598-018-22054-w","article-title":"Development of an injectable slow-release metformin formulation and evaluation of its potential antitumor effects","volume":"8","author":"Baldassari","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.173934_bib12","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1038\/sj.onc.1211024","article-title":"The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level","volume":"27","author":"Ben Sahra","year":"2008","journal-title":"Onogene"},{"key":"10.1016\/j.ejphar.2021.173934_bib13","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1158\/0008-5472.CAN-10-1769","article-title":"Metformin independently of AMPK, induces mTOR inhibition and cell-cycle arrest through REDDI","volume":"71","author":"Ben Sahra","year":"2011","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejphar.2021.173934_bib14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.biocel.2018.12.016","article-title":"Long term treatment of metformin impedes development of chemoresistance by regulating cancer stem cell differentiation through taurine generation in ovarian cancer cells","volume":"107","author":"Bishnu","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejphar.2021.173934_bib15","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.13262","article-title":"Epigenetic effects of metformin: from molecular mechanisms to clinical implications","volume":"20","author":"Bridgeman","year":"2018","journal-title":"Diabetes Obes. Metabol."},{"issue":"4","key":"10.1016\/j.ejphar.2021.173934_bib16","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/dmrr.2636","article-title":"The brighter (and evolutionarily older) face of the metabolic syndrome: evidence from Trypanosoma cruzi infection in CD-1 mice","volume":"31","author":"Brima","year":"2015","journal-title":"Diabetes Metab Res Rev."},{"issue":"8","key":"10.1016\/j.ejphar.2021.173934_bib1","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3390\/ijms17081298","article-title":"The antitumor effect of metformin is mediated by miR-26a in breast cancer","volume":"17","author":"Cabello","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejphar.2021.173934_bib17","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/CIRCRESAHA.116.308445","article-title":"Anti-inflammatory effects of metformin irrespective of diabetes","volume":"119","author":"Cameron","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2021.173934_bib157","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1136\/gutjnl-2015-310069","article-title":"Anti-angiogenic effect of metformin in human liver carcinogenesis related to metabolic syndrome","volume":"64","author":"Cauchy","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2021.173934_bib18","doi-asserted-by":"crossref","first-page":"40767","DOI":"10.18632\/oncotarget.8194","article-title":"Repurposing metformin for cancer treatment","volume":"7","author":"Chae","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.ejphar.2021.173934_bib19","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s41440-019-0212-z","article-title":"Metformin prevents vascular damage in hypertension through the AMPK\/ER stress pathway","volume":"42","author":"Chen","year":"2019","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2021.173934_bib20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.expneurol.2018.09.008","article-title":"Metformin attenuates diabetes-induced tau hyperphosphorylation in vitro and in vivo by enhancing autophagic clearance","volume":"311","author":"Chen","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2021.173934_bib21","doi-asserted-by":"crossref","first-page":"117498","DOI":"10.1016\/j.lfs.2020.117498","article-title":"Modulatory effect of metformin on cardiotoxicity induced by doxorubicin via MAPK and AMPK pathways","volume":"249","author":"Chen","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2021.173934_bib22","first-page":"41","article-title":"Metformin decreases growth of pancreatic cancer cells by decreasing reactive oxygen species: role of NOX4","volume":"465","author":"Cheng","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.ejphar.2021.173934_bib23","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/clpt.2010.266","article-title":"Rifampin enhances the glucose-lowering effect of metformin and increases OCT1 mRNA levels in healthy participants","volume":"89","author":"Cho","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2021.173934_bib24","doi-asserted-by":"crossref","unstructured":"Clinicaltrials.gov. Accessed on 06.06.2020.","DOI":"10.1055\/s-0040-1721631"},{"key":"10.1016\/j.ejphar.2021.173934_bib25","unstructured":"Clinicaltrialsregister.eu. accessed on 13.06.2020."},{"key":"10.1016\/j.ejphar.2021.173934_bib26","first-page":"42","article-title":"Metformin: a candidate drug for renal diseases","volume":"vol. 20","author":"Corremans","year":"2019"},{"key":"10.1016\/j.ejphar.2021.173934_bib27","first-page":"241","article-title":"AMPK activation: a therapeutic target for type 2 diabetes?","volume":"7","author":"Coughlan","year":"2014","journal-title":"Diabet. Metab Syndr Obes"},{"issue":"1","key":"10.1016\/j.ejphar.2021.173934_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s002109900152","article-title":"Effects of metformin on intestinal 5- hydroxytryptamine (5-HT) release and on 5-HT3 receptors","volume":"361","author":"Cubeddu","year":"2000","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2021.173934_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000481951","article-title":"Renoprotective effects of metformin","volume":"138","author":"De Broe","year":"2018","journal-title":"Nephron"},{"key":"10.1016\/j.ejphar.2021.173934_bib30","doi-asserted-by":"crossref","first-page":"c2181","DOI":"10.1136\/bmj.c2181","article-title":"Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B12 deficiency: randomised placebo controlled trial","volume":"340","author":"de Jager","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2021.173934_bib31","doi-asserted-by":"crossref","first-page":"896","DOI":"10.18632\/oncotarget.387","article-title":"Metformin, multi-faceted protection against cancer","volume":"2","author":"Del Barco","year":"2011","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ejphar.2021.173934_bib32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4161\/cc.11.2.18813","article-title":"Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers","volume":"11","author":"Deng","year":"2012","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.ejphar.2021.173934_bib33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bpobgyn.2009.09.005","article-title":"PCOS in adolescents","volume":"24","author":"Diamanti-Kandarakis","year":"2010","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.ejphar.2021.173934_bib34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/FJC.0000000000000599","article-title":"Cardioprotective effects of metformin","volume":"72","author":"Driver","year":"2018","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173934_bib35","first-page":"176","article-title":"Metformin with insulin relieves oxidative stress and confers renoprotection in type 1 diabetes in vivo","volume":"7","author":"Driver","year":"2018","journal-title":"J Nephropath"},{"key":"10.1016\/j.ejphar.2021.173934_bib36","first-page":"2869","article-title":"Metabolic effects of metformin in the failing heart","volume":"vol. 19","author":"Dziubak","year":"2018"},{"key":"10.1016\/j.ejphar.2021.173934_bib37","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1073\/pnas.1417636112","article-title":"Immune-mediated anti-tumour effect by type 2 diabetes drug, metformin","volume":"112","author":"Eikawa","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2021.173934_bib38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF01109053","article-title":"The wechsler memory scale-revised: psychometric characteristics and clinical application","volume":"2","author":"Elwood","year":"1991","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.ejphar.2021.173934_bib39","author":"European Medicines Agency (EMA)"},{"key":"10.1016\/j.ejphar.2021.173934_bib40","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2021.173934_bib41","author":"Food and Drug Administration"},{"key":"10.1016\/j.ejphar.2021.173934_bib42","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1172\/JCI40671","article-title":"Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1\/AMPK pathway via a decrease in hepatic energy state","volume":"120","author":"Foretz","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.ejphar.2021.173934_bib43","article-title":"Metformin beyond diabetes: pleiotropic benefits of metformin in attenuation of atherosclerosis","volume":"3","author":"Forouzandeh","year":"2014","journal-title":"J Am Heart Ass"},{"key":"10.1016\/j.ejphar.2021.173934_bib44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11892-017-0829-8","article-title":"Metformin: new preparations and nonglycemic benefits","volume":"17","author":"Fujita","year":"2017","journal-title":"Curr. Diabetes Rep."},{"issue":"1","key":"10.1016\/j.ejphar.2021.173934_bib45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4158\/CS-2019-0472","article-title":"Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinologists on the comprehensive type 2 diabetes management algorithm- 202 executive summary","volume":"26","author":"Garber","year":"2020","journal-title":"Endocr. Pract."},{"issue":"9","key":"10.1016\/j.ejphar.2021.173934_bib46","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/thoraxjnl-2012-203178","article-title":"Metformin reduces airway glucose permeability and hyperglycaemia\u2010induced Staphylococcus aureus load independently of effects on blood glucose","volume":"68","author":"Garnett","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.ejphar.2021.173934_bib47","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1007\/s00125-017-4337-9","article-title":"Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes","volume":"60","author":"Griffin","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2021.173934_bib48","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1161\/CIRCRESAHA.108.190918","article-title":"Activation of AMPK-activated protein kinase by metformin improves left ventricular function and survival in heart failure","volume":"104","author":"Gunderwar","year":"2009","journal-title":"Circ. Res."},{"issue":"11 Suppl. 1","key":"10.1016\/j.ejphar.2021.173934_bib49","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0735-1097(20)31579-5","article-title":"Metformin treatment in heart failure with preserved ejection fraction: a systematic review and meta regression analysis","volume":"75","author":"Halabi","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ejphar.2021.173934_bib50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2125.2011.04063.x","article-title":"Unlicensed use of metformin in children and adolescents in the UK","volume":"73","author":"Hsia","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.173934_bib51","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.18632\/oncotarget.23387","article-title":"Effect of metformin on kidney function in patients with type 2 diabetes mellitus and moderate chronic kidney disease","volume":"9","author":"Hsu","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2021.173934_bib53","author":"IMS Institute for Healthcare Informatics"},{"issue":"12","key":"10.1016\/j.ejphar.2021.173934_bib54","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.2337\/dc07-1686","article-title":"Metformin in heart failure","volume":"30","author":"Inzucchi","year":"2007","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.ejphar.2021.173934_bib55","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.ahj.2007.09.013","article-title":"Metformin therapy in patients with type 2 diabetes complicated by heart failure","volume":"154","author":"Inzucchi","year":"2007","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejphar.2021.173934_bib56","doi-asserted-by":"crossref","first-page":"108712","DOI":"10.1016\/j.biopha.2019.108712","article-title":"Metformin sensitises endometrial cancer cells to progestin by targeting TET1 to downregulate glyoxalase I expression","volume":"113","author":"Jiang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2021.173934_bib57","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ebiom.2018.12.052","article-title":"Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study","volume":"40","author":"Justice","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejphar.2021.173934_bib58","first-page":"19","article-title":"Clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"2","year":"2012","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.ejphar.2021.173934_bib60","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009992","article-title":"Use of antihypertensive agents and association with risk of adverse outcomes in chronic kidney disease: focus on angiotensin-converting enzyme inhibitors and angiotensin receptor blockers","volume":"7","author":"Ku","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.ejphar.2021.173934_bib61","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4103\/0974-1208.101012","article-title":"Effects of metformin use in pregnant patients with polycystic ovary syndrome","volume":"5","author":"Kumar","year":"2012","journal-title":"J. Hum. Reprod. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173934_bib62","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1463-1326.2000.00053.x","article-title":"Metformin and lactic acidosis in diabetic humans","volume":"2","author":"Lalau","year":"2000","journal-title":"Diabetes Obes. Metabol."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173934_bib63","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1463-1326.2010.01349.x","article-title":"Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomised clinical trials","volume":"13","author":"Lamanna","year":"2011","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.ejphar.2021.173934_bib65","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/jama.2015.0602","article-title":"Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review","volume":"313","author":"Levey","year":"2015","journal-title":"J. Am. Med. Assoc."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173934_bib66","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.bbrc.2016.08.087","article-title":"Metformin ameliorates obesity-associated hypertriglycemia in mice partly through the apolipoprotein A5 pathway","volume":"478","author":"Li","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.ejphar.2021.173934_bib67","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbrc.2019.03.077","article-title":"Metformin alleviates inflammatory response in non-alcoholic steatohepatitis by restraining signal transducer and activator of transcription 3-mediated autophagy inhibition in vitro and in vivo","volume":"513","author":"Li","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2021.173934_bib68","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1161\/CIRCULATIONAHA.116.023041","article-title":"Citizen petition to the US Food and Drug Administration to change prescribing guidelines: the metformin experience","volume":"134","author":"Lipska","year":"2016","journal-title":"Circuit"},{"key":"10.1016\/j.ejphar.2021.173934_bib69","first-page":"617","article-title":"Activation of AMPK by metformin renal cancer cell proliferation under glucose deprivation through its interaction with PKM2","volume":"vol. 15","author":"Liu","year":"2019"},{"key":"10.1016\/j.ejphar.2021.173934_bib70","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jad.2018.12.112","article-title":"Possible role of GLP-1 in antidepressant effects of metformin and exercise in CUMS mice","volume":"246","author":"Liu","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ejphar.2021.173934_bib72","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s00125-017-4364-6","article-title":"A new perspective on metformin therapy in type 1 diabetes","volume":"60","author":"Livingstone","year":"2017","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.ejphar.2021.173934_bib73","first-page":"1271","article-title":"Metformin triggers the intrinsic apoptotic response in human AGS gastric carcinoma cells by activating AMPK and suppressing mTOR\/AKT signaling","volume":"54","author":"Lu","year":"2019","journal-title":"Int. J. Oncol."},{"issue":"8","key":"10.1016\/j.ejphar.2021.173934_bib74","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1701-2163(16)32915-2","article-title":"Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies","volume":"30","author":"Lujan","year":"2008","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.ejphar.2021.173934_bib75","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12933-019-0860-y","article-title":"Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management","volume":"18","author":"Luo","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2021.173934_bib76","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4269\/ajtmh.20-0375","article-title":"Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis","volume":"103","author":"Luo","year":"2020","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"1","key":"10.1016\/j.ejphar.2021.173934_bib77","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13046-019-1090-6","article-title":"Low glucose and metformin-induced apoptosis of human ovarian cancer cells is connected to ASKI via mitochondrial and endoplasmic reticulum stress-associated pathways","volume":"38","author":"Ma","year":"2019","journal-title":"J. Exp. Clin. Canc. Res."},{"key":"10.1016\/j.ejphar.2021.173934_bib78","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature13270","article-title":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerolphosphate dehydrogenase","volume":"510","author":"Madiraju","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2021.173934_bib79","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/MED.0000000000000095","article-title":"Effects of metformin on weight loss: potential mechanisms","volume":"21","author":"Malin","year":"2014","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.ejphar.2021.173934_bib80","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1038\/s41598-019-42357-w","article-title":"Metformin prevention of doxorubicin resistance in MCF-7 and MDA-MB-231 involves oxidative stress generation and modulation of cell adaptation genes","volume":"9","author":"Marinello","year":"2019","journal-title":"Sci. Rep."},{"issue":"86","key":"10.1016\/j.ejphar.2021.173934_bib81","doi-asserted-by":"crossref","first-page":"35687","DOI":"10.18632\/oncotarget.26286","article-title":"A phase 2 trial with neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study","volume":"9","author":"Martin-Castillo","year":"2018","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ejphar.2021.173934_bib82","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00125-015-3844-9","article-title":"Metformin and the gastrointestinal tract","volume":"59","author":"McCreight","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2021.173934_bib83","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1158\/1535-7163.MCT-10-0731","article-title":"Interactions of tyrosine kinase inhibitors with organic cation transporters and multidrug and toxic compound extrusion proteins","volume":"10","author":"Minematsu","year":"2011","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ejphar.2021.173934_bib84","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1593\/tlo.13556","article-title":"Antidiabetic drug metformin prevents progression of pancreatic cancer by targeting in part cancer stem cells and mTOR signaling","volume":"6","author":"Mohammed","year":"2013","journal-title":"Transl Oncol"},{"issue":"3","key":"10.1016\/j.ejphar.2021.173934_bib85","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/acel.12075","article-title":"Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK\/NF-\u03baB activation","volume":"12","author":"Moiseeva","year":"2013","journal-title":"Aging Cell"},{"issue":"10","key":"10.1016\/j.ejphar.2021.173934_bib86","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.2337\/dc13-0229","article-title":"Increased risk of cognitive impairment in patients with diabetes is associated with metformin","volume":"36","author":"Moore","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2021.173934_bib87","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3389\/fmicb.2020.00435","article-title":"Metformin as a host-directed therapy for TB treatment","volume":"11","author":"Naicker","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejphar.2021.173934_bib88","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF01263443","volume":"14","author":"Nastrass","year":"1978","journal-title":"Biguanidines. Diabetologia."},{"issue":"8","key":"10.1016\/j.ejphar.2021.173934_bib89","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.2337\/dc06-9912","article-title":"Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes","volume":"29","author":"Nathan","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2021.173934_bib90","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2017.03.042","article-title":"Metformin-like antidiabetic, cardio- protective and non-glycemic effects of naringenin: molecular and pharmacological insights","volume":"803","author":"Nyane","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2021.173934_bib91","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.tranon.2019.02.001","article-title":"Metformin augments panobinostat's anti- bladder cancer activity by activating AMP-Activated Protein Kinase","volume":"12","author":"Okubo","year":"2019","journal-title":"Transl Oncol"},{"issue":"2","key":"10.1016\/j.ejphar.2021.173934_bib92","doi-asserted-by":"crossref","first-page":"105\u2010112","DOI":"10.1016\/j.parint.2015.11.001","article-title":"Atorvastatin and metformin administration modulates experimental Trichinella spiralis infection","volume":"65","author":"Othman","year":"2016","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ejphar.2021.173934_bib93","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bbi.2017.12.009","article-title":"Metformin treatment prevents amyloid plaque deposition and memory impairment in APP\/PS1 mice","volume":"69","author":"Ou","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejphar.2021.173934_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/jbc.M110.121806","article-title":"Metformin activates AMP kinase through inhibition of AMP deaminase","volume":"286","author":"Ouyang","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.ejphar.2021.173934_bib95","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/exd.13323","article-title":"Metformin alleviates ageing cellular phenotypes in Hutchinson\u2013Gilford progeria syndrome dermal fibroblasts","volume":"26","author":"Park","year":"2017","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ejphar.2021.173934_bib96","series-title":"Glucophage: Serving Diabetology for 40 Years","first-page":"p79","article-title":"Diabetes and the biguanidines: the mystery of each","author":"Pasic","year":"1997"},{"issue":"9","key":"10.1016\/j.ejphar.2021.173934_bib97","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1080\/03007995.2017.1279597","article-title":"Effect of metformin on clinical, metabolic and endocrine outcomes in women with polycystic ovary syndrome: a meta-analysis of randomised controlled trials","volume":"33","author":"Patel","year":"2017","journal-title":"Curr. Med. Res. Opin."},{"issue":"4","key":"10.1016\/j.ejphar.2021.173934_bib98","doi-asserted-by":"crossref","first-page":"758\u2010764","DOI":"10.1111\/jcmm.12784","article-title":"Metformin prevents the effects of Pseudomonas aeruginosa on airway epithelial tight junctions and restricts hyperglycaemia\u2010induced bacterial growth","volume":"20","author":"Patkee","year":"2016","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2021.173934_bib99","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF00562061","article-title":"Pharmacokinetics of metformin after intravenous and oral administration to man","volume":"16","author":"Pentik\u00e4inen","year":"1979","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2021.173934_bib100","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S2213-8587(13)70152-9","article-title":"Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial","volume":"2","author":"Preiss","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.ejphar.2021.173934_bib101","first-page":"100021","article-title":"Prepubertal metformin treatment in Fragile X syndrome alleviated macroorchidism: a case study","volume":"3","author":"Protic","year":"2019","journal-title":"Adv Clin Transl Res"},{"key":"10.1016\/j.ejphar.2021.173934_bib158","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098207","article-title":"Metformin Induces Apoptosis and Cell Cycle Arrest Mediated by Oxidative Stress, AMPK and FOXO3a in MCF-7 Breast Cancer Cells","volume":"9","author":"Queiroz","year":"2014","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.ejphar.2021.173934_bib102","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.tem.2013.05.004","article-title":"Repositioning metformin for cancer prevention and treatment","volume":"24","author":"Quinn","year":"2013","journal-title":"Trends Endocrinol. Metabol."},{"issue":"5","key":"10.1016\/j.ejphar.2021.173934_bib103","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/CIRCULATIONAHA.117.031735","article-title":"Repurposing metformin for cardiovascular disease","volume":"137","author":"Rena","year":"2018","journal-title":"Circuit"},{"issue":"9","key":"10.1016\/j.ejphar.2021.173934_bib104","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.ejphar.2021.173934_bib105","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2164\/jandrol.111.013714","article-title":"Addition of metformin to sildenafil treatment for erectile dysfunction in eugonadal nondiabetic men with insulin resistance. A prospective, randomised, double\u2010blind pilot study","volume":"33","author":"Rey-Valzacchi","year":"2012","journal-title":"J. Androl."},{"issue":"2","key":"10.1016\/j.ejphar.2021.173934_bib106","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.tips.2012.11.005","article-title":"Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects","volume":"34","author":"Riedmaier","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173934_bib107","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ajog.2017.06.003","article-title":"Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity","volume":"217","author":"Romero","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ejphar.2021.173934_bib108","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1007\/s12035-017-0752-7","article-title":"Metformin inhibits the development of l-DOPA- induced dyskinesia in a murine model of Parkinson\u2019s Disease","volume":"55","author":"Ryu","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2021.173934_bib109","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.biopha.2017.12.023","article-title":"Metformin treatment decreases nitroxidative stress, restores nitric oxide bioavailability and endothelial function beyond glucose control","volume":"98","author":"Sambe","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.ejphar.2021.173934_bib110","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/(SICI)1096-9136(199808)15:8<651::AID-DIA628>3.0.CO;2-A","article-title":"Effect of metformin on bile salt circulation and intestinal motility in type 2 diabetes mellitus","volume":"15","author":"Scarpello","year":"1998","journal-title":"Diabet. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2021.173934_bib111","first-page":"329","article-title":"Metformin and lactic acidosis","volume":"66","author":"Scheen","year":"2011","journal-title":"Acta Clin. Belg."},{"key":"10.1016\/j.ejphar.2021.173934_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2020.07.006","article-title":"Metformin and COVID-19: from cellular mechanisms to reduced Mortality","author":"Scheen","year":"2020","journal-title":"Diabetes Metab."},{"issue":"5","key":"10.1016\/j.ejphar.2021.173934_bib113","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1053\/gast.2001.23258","article-title":"Prevention of pancreatic cancer induction in hamsters by metformin","volume":"120","author":"Schneider","year":"2001","journal-title":"Gastroenterol."},{"key":"10.1016\/j.ejphar.2021.173934_bib114","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.3390\/ijms19102850","article-title":"Pleiotropic effects of metformin on cancer","volume":"19","author":"Schulten","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2021.173934_bib115","doi-asserted-by":"crossref","first-page":"108183","DOI":"10.1016\/j.diabres.2020.108183","article-title":"Metformin in COVID-19: a possible role beyond diabetes","volume":"164","author":"Sharma","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ejphar.2021.173934_bib116","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1038\/cddis.2012.13","article-title":"Therapeutic metformin\/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy","volume":"3","author":"Shi","year":"2012","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.ejphar.2021.173934_bib117","doi-asserted-by":"crossref","first-page":"662","DOI":"10.2174\/138945008785132402","article-title":"Targeting Sphk1 as new strategy against cancer","volume":"9","author":"Shida","year":"2008","journal-title":"Curr. Drug Targets"},{"issue":"7","key":"10.1016\/j.ejphar.2021.173934_bib118","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.4049\/jimmunol.1901310","article-title":"AMP-activated protein kinase restricts Zika virus replication in endothelial cells by potentiating innate antiviral responses and inhibiting glycolysis","volume":"2204","author":"Singh","year":"2020","journal-title":"J. Immunol."},{"issue":"263","key":"10.1016\/j.ejphar.2021.173934_bib119","doi-asserted-by":"crossref","first-page":"263ra159","DOI":"10.1126\/scitranslmed.3009885","article-title":"Metformin as adjunct antituberculosis therapy","volume":"6","author":"Singhal","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejphar.2021.173934_bib120","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/srep00362","article-title":"Metformin kills and radiosensitises cancer cells and preferentially kills cancer stem cells","volume":"2","author":"Song","year":"2012","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.ejphar.2021.173934_bib121","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2337\/dc14-0500","article-title":"Metformin and cancer: mounting evidence against an association","volume":"37","author":"Suissa","year":"2014","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.ejphar.2021.173934_bib122","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/1440-1681.13073","article-title":"NF\u2010\u03baB as the mediator of metformin's effect on aging and age\u2010related diseases","volume":"46","author":"Sultuybek","year":"2019","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"7618","key":"10.1016\/j.ejphar.2021.173934_bib123","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/bmj.39255.669444.AE","article-title":"Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated?","volume":"335","author":"Tahrani","year":"2007","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.ejphar.2021.173934_bib124","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1128\/AAC.01471-16","article-title":"Moxifloxacin is a potent in vitro inhibitor of OCT- and MATE-mediated transport of metformin and ethambutol","volume":"60","author":"Te Brake","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2021.173934_bib125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173934_bib126","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejphar.2021.173934_bib127","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes","volume":"352","author":"The UK Prospective Diabetes Study Group","year":"1998","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejphar.2021.173934_bib128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/cancers11020209","article-title":"Metformin treatment suppresses melanoma cell growth and motility through modulation of microRNA expressions","volume":"11","author":"Tseng","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ejphar.2021.173934_bib129","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40256-018-0266-3","article-title":"Cardioprotection by metformin: beneficial effects beyond glucose reduction","volume":"18","author":"Varjabedian","year":"2018","journal-title":"Am. J. Cardiovasc. Drugs"},{"issue":"6","key":"10.1016\/j.ejphar.2021.173934_bib130","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.2337\/db14-1225","article-title":"Metformin inhibits monocyte- to-macrophage differentiation via AMPK mediated inhibition of STAT3 activation: potential role in atherosclerosis","volume":"64","author":"Vasamsetti","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2021.173934_bib131","doi-asserted-by":"crossref","first-page":"6978625","DOI":"10.1155\/2016\/6978625","article-title":"The role of metformin in controlling oxidative stress in muscle of diabetic rats","author":"Vilela","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.ejphar.2021.173934_bib132","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/humrep\/dew287","article-title":"The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria?","volume":"32","author":"Wang","year":"2017","journal-title":"Humanit. Rep."},{"issue":"42","key":"10.1016\/j.ejphar.2021.173934_bib133","doi-asserted-by":"crossref","first-page":"44579","DOI":"10.18632\/oncotarget.6373","article-title":"Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2\/HIF-1\u03b1\/VEGF secretion axis","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2021.173934_bib134","article-title":"Metformin inhibited squamous cell proliferation in vitro and in vivo and enhanced antitumor effects of cisplatin","author":"Wang","year":"2017","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.ejphar.2021.173934_bib135","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/acel.12587","article-title":"Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism","volume":"16","author":"Wang","year":"2017","journal-title":"Aging Cell"},{"key":"10.1016\/j.ejphar.2021.173934_bib136","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02242","article-title":"Metformin inhibits mitochondrial complex I of cancer cells to reduce turmorigenesis","volume":"3","author":"Wheaton","year":"2014","journal-title":"eLife"},{"key":"10.1016\/j.ejphar.2021.173934_bib137","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10557-012-6425-x","article-title":"Chronic metformin-associated cardioprotection against infarction: not just a glucose lowering phenomenon","volume":"27","author":"Whittington","year":"2013","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejphar.2021.173934_bib138","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.tube.2019.02.004","article-title":"Metformin as a host directed therapeutic in tuberculosis: is there promise?","volume":"115","author":"Wing","year":"2019","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ejphar.2021.173934_bib139","series-title":"WHO Model List of Essential Medicines. 19th List. 2015","author":"World Health Organization","year":"2015"},{"issue":"2","key":"10.1016\/j.ejphar.2021.173934_bib140","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.2007.56-b","article-title":"Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain, a randomised controlled trial","volume":"299","author":"Wu","year":"2008","journal-title":"J. Am. Med. Assoc."},{"issue":"7","key":"10.1016\/j.ejphar.2021.173934_bib141","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.cell.2016.11.055","article-title":"An ancient unified mechanism for metformin growth inhibition in C. elegans and cancer","volume":"167","author":"Wu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2021.173934_bib142","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nm.4345","article-title":"Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug","volume":"23","author":"Wu","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2021.173934_bib143","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2017.5650","article-title":"Metformin and pioglitazone combination therapy ameliorate polycystic ovary syndrome through AMPK\/PI3K\/JNK pathway","author":"Wu","year":"2017","journal-title":"Exp. Therap. Med. doi.org\/"},{"key":"10.1016\/j.ejphar.2021.173934_bib156","doi-asserted-by":"crossref","first-page":"43373","DOI":"10.1038\/srep43373","article-title":"Combining metformin and nelfinavir exhibits synergistic effects against the growth of human cervical cancer cells and xenograft in nude mice","volume":"7","author":"Xia","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.173934_bib144","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejphar.2019.01.045","article-title":"Metformin combined with nelfinavir induces SIRT3\/mROS-dependent autophagy in human cervical cancer cells and xenograft in nude mice","volume":"848","author":"Xia","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejphar.2021.173934_bib145","doi-asserted-by":"crossref","first-page":"597\u2010603","DOI":"10.1111\/jvh.12187","article-title":"Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells","volume":"21","author":"Xun","year":"2014","journal-title":"J. Viral Hepat."},{"issue":"10","key":"10.1016\/j.ejphar.2021.173934_bib146","first-page":"3289","article-title":"Metformin inhibits cell growth by upregulating microRNA-26a in renal cancer cells","volume":"7","author":"Yang","year":"2014","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.ejphar.2021.173934_bib147","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1038\/oncsis.2015.18","article-title":"Metformin induces ER-dependent stress apoptosis through miR-708-5p\/NNAT pathway in prostate cancer","volume":"4","author":"Yang","year":"2015","journal-title":"Oncogenesis"},{"issue":"9","key":"10.1016\/j.ejphar.2021.173934_bib148","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1002\/jcp.26505","article-title":"Metformin attenuates folic\u2010acid induced renal fibrosis in mice","volume":"233","author":"Yi","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2021.173934_bib149","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6234758","article-title":"The effect of metformin in experimentally induced animal models of epileptic seizure","author":"Yimer","year":"2019","journal-title":"Behav. Neurol."},{"key":"10.1016\/j.ejphar.2021.173934_bib150","article-title":"The effect of metformin on the efficacy of antiviral therapy in patients with genotype 1 chronic hepatitis C and insulin resistance","volume":"16","author":"Yu","year":"2013","journal-title":"Int. J. Infect. Dis."},{"issue":"21","key":"10.1016\/j.ejphar.2021.173934_bib151","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1158\/0008-5472.CAN-06-1500","article-title":"Metformin is an AMP-kinase dependent growth inhibitor for breast cancer cells","volume":"661","author":"Zakikhani","year":"2006","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejphar.2021.173934_bib152","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","article-title":"Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity","volume":"502","author":"Zeng","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.ejphar.2021.173934_bib153","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbrc.2014.04.130","article-title":"Metformin protects against seizures, learning and memory impairments and oxidative damage induced by pentylenetetrazole-induced kindling in mice","volume":"448","author":"Zhao","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2021.173934_bib154","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1038\/onc.2016.391","article-title":"Metformin alters DNA methylation genome-wide via the H19\/SAHH axis","volume":"36","author":"Zhong","year":"2017","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.ejphar.2021.173934_bib155","first-page":"955","article-title":"New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463","volume":"9","author":"Zhu","year":"2017","journal-title":"Aging (N Y)"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992100087X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992100087X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:46:17Z","timestamp":1757976377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992100087X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":154,"alternative-id":["S001429992100087X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.173934","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin turns 62 in pharmacotherapy: Emergence of non-glycaemic effects and potential novel therapeutic applications","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.173934","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173934"}}